Analysts Set Ardent Health, Inc. (NYSE:ARDT) Target Price at $14.12

Ardent Health, Inc. (NYSE:ARDT) has been given an average rating of “Hold” by the fourteen analysts that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, five have given a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $14.0417.

A number of research analysts recently weighed in on ARDT shares. Wall Street Zen lowered shares of Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Weiss Ratings restated a “sell (d+)” rating on shares of Ardent Health in a research note on Friday, June 12th. Truist Financial reduced their target price on Ardent Health from $13.00 to $12.00 and set a “buy” rating for the company in a report on Tuesday. Zacks Research raised Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Finally, UBS Group lifted their price target on Ardent Health from $13.00 to $13.50 and gave the stock a “buy” rating in a report on Thursday, May 7th.

Insider Buying and Selling

In related news, CFO Alfred Lumsdaine bought 10,000 shares of the company’s stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $8.81 per share, for a total transaction of $88,100.00. Following the completion of the purchase, the chief financial officer directly owned 329,183 shares in the company, valued at $2,900,102.23. The trade was a 3.13% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 1.90% of the company’s stock.

Hedge Funds Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. LSV Asset Management purchased a new stake in shares of Ardent Health in the 4th quarter worth about $963,000. Prescott Group Capital Management L.L.C. purchased a new position in shares of Ardent Health during the fourth quarter valued at about $1,077,000. Denali Advisors LLC increased its position in shares of Ardent Health by 35.0% during the fourth quarter. Denali Advisors LLC now owns 249,450 shares of the company’s stock valued at $2,203,000 after buying an additional 64,650 shares during the period. Strs Ohio raised its stake in Ardent Health by 47.2% in the fourth quarter. Strs Ohio now owns 62,400 shares of the company’s stock worth $551,000 after buying an additional 20,000 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Ardent Health by 126.1% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 10,400 shares of the company’s stock valued at $92,000 after acquiring an additional 5,800 shares in the last quarter.

Ardent Health Stock Down 0.6%

ARDT stock opened at $10.13 on Monday. The firm has a market capitalization of $1.45 billion, a PE ratio of 10.67, a P/E/G ratio of 2.40 and a beta of 0.76. The company has a quick ratio of 2.00, a current ratio of 2.12 and a debt-to-equity ratio of 0.62. Ardent Health has a twelve month low of $7.71 and a twelve month high of $15.48. The stock’s 50 day moving average is $9.62 and its 200-day moving average is $9.29.

Ardent Health (NYSE:ARDT) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.10. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Ardent Health had a return on equity of 13.85% and a net margin of 2.09%.Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. Sell-side analysts expect that Ardent Health will post 1.06 EPS for the current fiscal year.

About Ardent Health

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.